Eur Heart J Cardiovasc Imaging
July 2020
Aims: Vitamin K antagonists (VKAs) are suspected of causing aortic valve calcification (AVC). The objective of this study was to clarify whether patients undergoing VKA treatment have increased AVC scores compared to patients treated with new oral anticoagulants (NOACs) and patients who never have been treated with VKA/NOAC.
Methods And Results: We included participants from the population-based DANCAVAS trial (n = 15 048).